CMLT News and Press, EQRx Inc Com

NEW YORK, NY / ACCESSWIRE / October 20, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CM Life Sciences III Inc. ("CM Life Sciences"), which was acquired by EQRx, Inc. ("EQRx") (NASDAQ:EQRX) on August 5, 2021. Investors who purchased CM...

Business combination with CM Life Sciences III results in approximately $1.3 billion in cash proceeds Combined company to trade on Nasdaq Global Market under ticker “EQRX” NEW YORK and CAMBRIDGE, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences III (Nasdaq...

Six multi-billion dollar deals announced last week. VICI Properties acquires MGM Growth Properties for $17.2 billion. Veoneer receives a superior bid from Qualcomm. For further details see: Merger Arbitrage Mondays - Veoneer Receives A Superior Bid From Qualcomm

SPAC CM Life Sciences III (NASDAQ:CMLT), which is backed by Corvex's Keith Meister and Casdin Capital, agreed to a  deal to take drug-price startup EQRx public. The transaction is expected to provide up to $1.8B in cash proceeds for EQRX, according to a statement. The deal includes a $1....

A team with a track record of prior success has raised its largest SPAC yet. The SPAC is about two months old, meaning it is becoming more likely to do a deal going forward. Because of the track record and the reputation of the team, the warrants are trading relatively rich. ...